Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Operating Expenses

$1.60B

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Operating Expenses

Latest reported$1.60Bperiod endingJun 30, 2026

Latest reported$1.60Bperiod endingJun 30, 2026

VRTX Quarterly Operating Expenses ($0.00 → $1.60B)

Quarterly operating expenses

High-resolution chart · PNG

VRTX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Expenses — Quarterly (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	37,970,000
Mar 31, 2001	33,615,000
Dec 31, 2000	26,743,000
Sep 30, 2000	30,205,000
Jun 30, 2000	28,592,000
Mar 31, 2000	27,187,000
Dec 31, 1999	28,500,000
Sep 30, 1999	24,500,000
Jun 30, 1999	25,900,000
Mar 31, 1999	25,600,000
Dec 31, 1998	25,400,000
Sep 30, 1998	21,600,000
Jun 30, 1998	17,900,000
Mar 31, 1998	16,400,000
Dec 31, 1997	18,700,000
Sep 30, 1997	20,200,000
Jun 30, 1997	14,200,000
Mar 31, 1997	13,300,000
Dec 31, 1996	11,000,000
Sep 30, 1996	11,100,000
Jun 30, 1996	12,300,000
Mar 31, 1996	11,900,000
Dec 31, 1995	11,500,000
Sep 30, 1995	11,300,000
Jun 30, 1995	17,500,000
Mar 31, 1995	12,000,000
Dec 31, 1994	12,100,000
Sep 30, 1994	11,100,000
Jun 30, 1994	11,100,000
Mar 31, 1994	9,700,000
Dec 31, 1993	10,500,000
Sep 30, 1993	8,200,000
Jun 30, 1993	6,500,000
Mar 31, 1993	5,200,000
Dec 31, 1992	4,600,000
Sep 30, 1992	4,300,000
Jun 30, 1992	1,300,000
Mar 31, 1992	3,600,000
Dec 31, 1991	3,000,000
Sep 30, 1991	2,600,000
Jun 30, 1991	2,600,000
Mar 31, 1991	0
Dec 31, 1990	-6,400,000
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.